ophthalomogy, OPHTHALOMOGY, ocular pharmacology
ophthalomogy, OPHTHALOMOGY, ocular pharmacology

 

 

 

 

ophthalomogy, OPHTHALOMOGY, ocular pharmacology
GUIDELINES FOR SUBMISSION OF ABSTRACTS

SUBMISSION OPTIONS

Abstracts may be submitted in English in one of the following ways: 
via this website 
or
by regular mail

Important: 
Do not submit multiple versions of the same abstract - 
please use only one method of submission!

 

SUBMISSION BY THIS WEBSITE (ONLINE)
Abstracts may be submitted using this website: by filling out the Abstract Form

   


SUBMISSION BY REGULAR MAIL 

Download the Abstract Form [Word file; 45Kb]
  

a. The entire abstract (250 words) including title, author(s), institution and country must fit WITHIN THE RECTANGLE. White paper of the same dimensions may be used.

b. Type using a laser or high quality printer with minimum font size of 10pt. Standard abbreviations may be used.

c. Abstracts accepted for presentation will be published in the Abstract Book exactly as submitted; therefore abstracts must be submitted camera-ready. Avoid errors, corrections and misspellings.

d. Mail abstracts (original and 2 copies) to:

Secretariat, ISOPP4
PO Box 50006, Tel Aviv 61500, Israel
For courier service only:
9th Floor, Industry House, 29 Hamered Street, Tel Aviv 68125, Israel


DISCLOSURE OF FACULTY RELATIONSHIPS - Policy Statement
The Congress requires that audiences at this educational program be informed of a presenter's academic and professional affiliations, as well as other commercial relationships relevant to the content of the material that is presented.
This policy allows the listener/attendee to be fully informed in evaluating the information being presented. The situations may include, but are not limited to 1) stock options or bond holdings, 2) research grants, 3) employment (full or part time), 4) ownership or partnership, 5) consulting fees or other remuneration received by the presenter or his/her immediate family, 6) nonremunerative positions of influence such as officer, board member, trustee, or public spokesperson. The disclosure should be shown as an indication (by an*) for those presenters who have stated that a relationship(s) exists relevant to the topic(s) being discussed.